Medexus Pharmaceuticals Inc(TSE:MDP)
CA$5.43-0.26 (-4.57%)
TSE:MDP
Medexus Pharmaceuticals Inc financials statements
CA$5.43
At close:-0.26 (-4.57%)
Want to see TSE:MDP full AI Analyst Report?
Medexus Pharmaceuticals Inc (MDP) Income Statement
73 Followers
Medexus Pharmaceuticals Inc Income Statement
Last quarter (Q1 2027), Medexus Pharmaceuticals Inc's total revenue was C$28.59M, an increase of 16.13% from the same quarter last year. In Q1, Medexus Pharmaceuticals Inc's net income was C$547.66K. See Medexus Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| C$ 99.33M | C$ 108.33M | C$ 108.10M | C$ 76.70M | C$ 79.66M | |
| C$ 54.41M | C$ 56.58M | C$ 60.04M | C$ 37.93M | C$ 42.01M | |
| C$ 48.58M | C$ 48.36M | C$ 52.42M | C$ 50.30M | C$ 43.38M | |
| Depreciation and Amortization | C$ 9.73M | C$ 7.18M | C$ 6.08M | C$ 6.14M | C$ 5.98M |
| C$ 12.66M | C$ 16.81M | C$ 14.65M | C$ 14.55M | C$ -15.71M | |
| C$ 5.83M | C$ 8.22M | C$ 7.61M | C$ -12.38M | C$ -1.38M | |
| C$ -8.11M | C$ -6.78M | C$ -12.65M | C$ 8.56M | C$ -30.13M | |
| C$ -2.27M | C$ 1.44M | C$ -5.04M | C$ -3.82M | C$ -31.50M | |
| C$ -2.39M | C$ 2.25M | C$ 1.22M | C$ -2.88M | C$ -28.26M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.07 | C$ 0.09 | C$ 0.08 | C$ -0.19 | C$ -1.86 |
| Diluted EPS | C$ -0.07 | C$ 0.08 | C$ 0.08 | C$ -0.19 | C$ -1.86 |
| Weighted Average Shares Outstanding | 32.32M | 25.82M | 19.98M | 19.45M | 15.20M |
| Weighted Average Shares Outstanding (Diluted) | 32.32M | 26.51M | 20.52M | 19.86M | 15.20M |
Currency in CAD
